Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $552.4500 (2.3%) ($545.0000 - $559.6500) on Tue. Jul. 28, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 12.63% (three month average) | | RSI | 78 | | Latest Price | $552.4500(2.3%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.1% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(66%) XLV(54%) XBI(51%) QQQ(43%) SPY(42%) | | Factors Impacting REGN price | REGN will decline at least -6.315% in a week (0% probabilities).
VIXM(-17%) TLT(-10%) SHY(-5%) UUP(-4%) TIP(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -6.315% (StdDev 12.63%) | | Hourly BBV | 0 () | | Intraday Trend | -0.2% | | | | | |
|
| 5 Day Moving Average | $549.49(0.54%) | | 10 Day Moving Average | $551.48(0.18%) | | 20 Day Moving Average | $535.89(3.09%) | | To recent high | -1.6% | | To recent low | 20.8% | | Market Cap | $58.576b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |